< Back
IAS 2025, the 13th IAS Conference on HIV Science

IAS 2025, the 13th IAS Conference on HIV Science

Conference login

Registration is open

Standard registration closes on Tuesday, 6 May at 23:59 CET.

  •  days
  •  Hours
  •  Minutes
  •  Seconds
Register now
alternative text

Keep your IAS 2025 registration up to date!

If you have changed your email address or lost access to the email used for your IAS 2025 registration, please contact info@ias2025.org to update your details and ensure you receive important conference communications.

IAS 2025, the 13th IAS Conference on HIV Science, will take place in Kigali, Rwanda, and virtually, from 13 to 17 July 2025, with pre-conferences on 13 July.

The IAS Conference on HIV Science is the world’s most influential meeting on HIV research and its applications. This biennial conference presents the critical advances in basic, clinical and operational HIV research that move science into policy and practice. Through its open and inclusive programme, the meeting sets the gold standard of HIV science, featuring highly diverse and cutting-edge research.

IAS 2025 will also address the current political and financial issues affecting the HIV response, including the implications for Africa and around the world.

Featured speakers

Morkor Newman Owiredu

Morkor Newman Owiredu

World Health Organization, Switzerland

View

Morkor Newman Owiredu

Morkor Newman Owiredu is a Medical Officer at the World Health Organization in Geneva, leading work on the elimination of vertical transmission and women’s health in HIV in the Treatment and Care team of the Global HIV, Hepatitis and STI Programmes. She is currently coordinating the implementation and assessments of responses to the WHO flagship “triple elimination initiative” to end vertical transmission of HIV, syphilis and hepatitis B.

Placide Mbala Kingebeni

Placide Mbala Kingebeni

University of Kinshasa and National Institute of Biomedical Research, the Democratic Republic of the Congo (DRC) 

View

Placide Mbala Kingebeni

Placide Mbala Kingebeni is an Associate Professor at the University of Kinshasa, School of Medicine, and Head of the Epidemiology and Global Health Division and Director of the Clinical Research Center at the National Institute of Biomedical Research in the DRC. With extensive experience in medical biology, his research focuses on viral zoonoses with risk factors for human contamination. As PI and co-investigator for university and US-funded grants, Placide Mbala laid the groundwork for research projects in remote DRC areas, where most outbreaks occur. He contributed to several study projects, such as clinical characterization of human mpox infection in the DRC, molecular identification and characterization of novel simian T cell lymphotropic viruses in DRC nonhuman primate bush meat, and investigations and characterization of zoonotic pathogens, such as Ebola and mpox. He has been involved in investigations of the COVID-19 pandemic and Ebola outbreaks in the DRC since 2014.

Gad Murenzi

Gad Murenzi

Research for Development and Rwanda Military Referral and Teaching Hospital (RMRTH), Rwanda

View

Gad Murenzi

Gad Murenzi is the Director of the Einstein-Rwanda Research and Capacity Building Program based at Research for Development and the Rwanda Military Referral and Teaching Hospital (RMRTH) in Kigali, Rwanda. He is responsible for leading scientific research and capacity-building activities of the programme, which focuses on HIV/HPV and co-morbidities. His research interests and expertise include HIV, cancer (mainly HPV-related cancers) and other NCDs. Previously, he served as the site investigator and primary colposcopist of a cervical cancer screening project among 5,000 women living with HIV and coordinator of research laboratory development at RMRTH. In addition, he leads studies on HPV vaccine effectiveness among women living with HIV, anal/penile HPV and anal squamous intraepithelial lesions and cancer. He is also a high-resolution anoscopy provider and an anatomic pathologist.

Kathryn Anastos

Kathryn Anastos

Albert Einstein College of Medicine, United States

View

Kathryn Anastos

Kathryn Anastos, MD, is a physician executive, clinician and medical researcher who has provided clinical care and operational and clinical leadership in the South Bronx of New York City for more than 20 years. Kathryn trained and practices as a primary care internist with expertise in the comprehensive care of people living with HIV and HIV in women. A founder of WE-ACTx (Women’s Equity in Access to Care and Treatment), a community-based organization devoted to developing high-quality ambulatory medical services for women living with HIV in Rwanda, she now serves as its Director of Clinical Systems and Scientific Programs. WE-ACTx collaborates with the Rwandan government and 24 NGOs to provide comprehensive HIV primary care to women survivors of genocidal rape. She has also developed and serves as principal investigator of the Rwandan Women's Cohort Study, funded by the National Institutes of Health. She is a Professor of Medicine, Epidemiology and Population Health at the Albert Einstein College of Medicine.

View all featured speakers

Submissions

Submit an abstract

Submit a late-breaker abstract

View
Submit an abstract

Submit an mpox-related abstract

View
Submit an Affiliated Independent Event

Submit an Affiliated Independent Event

View
Book a pre-conference

Book a pre‑conference

View

View all submissions

Programme at a glance

Time displayed in local Rwanda time (CAT).

View programme at a glance

pattern above

Sign up to receive the latest IAS 2025 updates

Sign up now
alternative text

Stay vigilant against scams! We have been alerted to cases of phishing emails impersonating the IAS 2025 “Global Travel Team” and targeting speakers. These emails are fraudulent. All official communication from IAS, the International AIDS Society, on behalf of IAS 2025 will come from an IAS 2025 email address, such as accommodation@ias2025.org. If you are unsure about an email or suspect a scam, please contact us at info@ias2025.org.

Language matters

At the IAS, we actively use language that puts people first. This is because words have power: they bestow or remove dignity, build or break stigma, and divide or unite the HIV response. Through the words we choose to use at the IAS, we acknowledge that a person is so much more than a condition; we promote inclusivity, dialogue and equality.

Find out more

pattern below

Meet the IAS 2025 Organizing Committee

View

IAS 2025 sponsorship opportunities

View

FAQs

View

Inclusion is a priority for IAS 2025. We offer lower registration fees for delegates from upper-middle, lower-middle and low-income countries, as well as students, postdocs and young people.

Find out more

Quick links to our activities

Closing scientific gaps

Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global HIV Vaccine Enterprise Towards an HIV Cure

Disseminating the latest research

IAS Educational Fund Journal of the International AIDS Society (JIAS)

Improving health services

Community-Led Monitoring Differentiated Service Delivery Heart of Stigma Mark Wainberg Fellowship Programme Person-Centred Care Youth Hub

Conferences

International AIDS Conference IAS Conference on HIV Science HIV Research for Prevention Conference

Get involved

Become an IAS change maker Corporate Partnership Programme Me and My Healthcare Provider IAS membership

The IAS promotes the use of non-stigmatizing, people-first language. The translations are all automated in the interest of making our content as widely accessible as possible. Regretfully, they may not always adhere to the people-first language of the original version.